Geraldine Henwood

Insider Reports History

Location
88 Sidney St, Cambridge, MA
Signature
/s/ Jillian Dilmore, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geraldine Henwood:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Baudax Bio, Inc. President and CEO, Director Common Stock 2.43K $752 $0.31 Dec 15, 2022 Direct
Baudax Bio, Inc. President and CEO, Director Common Stock 14 $4.00 $0.31 Dec 15, 2022 By spouse
Baudax Bio, Inc. President and CEO, Director Stock Option (right to buy) 821K Dec 22, 2021 Direct
Recro Pharma, Inc. Director Stock Option (right to buy) 38K Apr 20, 2021 Direct

Insider Reports Filed by Geraldine Henwood

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BXRX Baudax Bio, Inc. Dec 15, 2022 1 $3.06K 4 Dec 19, 2022 President and CEO, Director
BXRX Baudax Bio, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 President and CEO, Director
BXRX Baudax Bio, Inc. Dec 15, 2021 2 -$5.78K 4 Dec 23, 2021 President and CEO, Director
BXRX Baudax Bio, Inc. Dec 5, 2021 1 -$3.2K 4 Dec 14, 2021 President and CEO, Director
BXRX Baudax Bio, Inc. Sep 22, 2021 1 $4.8K 4 Sep 23, 2021 President and CEO, Director
BXRX Baudax Bio, Inc. May 7, 2021 1 $4.99K 4 May 10, 2021 President and CEO, Director
SCTL Recro Pharma, Inc. Apr 20, 2021 1 $0 4/A May 17, 2021 Director